Laura Vizkeleti

Laura Vizkeleti

93 Üllöi Str
Budapest, BU 1091, Hungary

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma.

Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma.

Journal: Scientific reports
Published: April 17, 2024

Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer.

Utilizing a dual endogenous reporter system to identify functional regulators of aberrant stem cell and differentiation activity in colorectal cancer.

Journal: bioRxiv : the preprint server for biology
Published: January 31, 2024

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.

Journal: Scientific reports
Published: August 08, 2023

Potential role of type I interferon in the genetic progression of melanoma

Potential role of type I interferon in the genetic progression of melanoma

Journal: Magyar onkologia
Published: April 13, 2023

Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers.

Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers.

Journal: Cells
Published: April 10, 2023

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.

Nucleotide excision repair deficiency is a targetable therapeutic vulnerability in clear cell renal cell carcinoma.

Journal: bioRxiv : the preprint server for biology
Published: February 17, 2023

Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system.

Identifying regulators of aberrant stem cell and differentiation activity in colorectal cancer using a dual endogenous reporter system.

Journal: Nature communications
Published: February 02, 2023

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries.

The Driverless Triple-Wild-Type (BRAF, RAS, KIT) Cutaneous Melanoma: Whole Genome Sequencing Discoveries.

Journal: Cancers
Published: January 30, 2023

Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy.

Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy.

Journal: International journal of molecular sciences
Published: January 28, 2022

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma.

Organ Specific Copy Number Variations in Visceral Metastases of Human Melanoma.

Journal: Cancers
Published: October 13, 2021

Molecular background of BRAF inhibitor induced resistance in BRAFV600E mutant melanoma cell lines

Molecular background of BRAF inhibitor induced resistance in BRAFV600E mutant melanoma cell lines

Journal: Magyar onkologia
Published: April 21, 2021

EGFR protein is a negative prognostic and predictive factor in wild-type RAS colorectal cancer

EGFR protein is a negative prognostic and predictive factor in wild-type RAS colorectal cancer

Journal: Magyar onkologia
Published: April 18, 2021
Showing 1-12 of 33

Last Updated: 09/26/2026